Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis

NCT04886258 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Symptomatic Knee Osteoarthritis

Interventions

DRUG: DFV890
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals